Jushi Holdings (JUSHF) Gross Margin (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Gross Margin of 44.22% for Q2 2026, down 24.0% year-over-year from 58.19% in Q2 2025, and down 1.67% quarter-over-quarter from 44.97% in Q1 2026.
Jushi Holdings (JUSHF) Gross Margin (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Gross Margin for 6 consecutive years, with 44.22% the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Margin fell 24.0% year-over-year to 44.22%; the TTM figure through Jun 2026 stood at 44.41% (up 224.0% YoY), while the FY2025 annual figure was 43.35%, down 259.0% from the prior year.
- Gross Margin eased to 44.22% in Q2 2026 per JUSHF's latest filing, from 44.97% in the prior quarter.
- Across five years, Gross Margin topped out at 50.42% in Q2 2024 and bottomed at 28.58% in Q4 2022.
- Historically, Gross Margin has averaged 41.85% across 5 years, with a median of 43.23% in 2023.
- Annual changes were most pronounced in 2023 — Gross Margin soared 1197 bps — and 2025, when it sank 902 bps.
- Jushi Holdings' Gross Margin stood at 28.58% in 2022, then soared by 41 bps to 40.16% in 2023, then retreated by 4 bps to 38.58% in 2024, then advanced by 9 bps to 41.87% in 2025, then climbed by 6 bps to 44.22% in 2026.
- Business Quant data shows JUSHF's Gross Margin at 44.22% in Q2 2026, 44.97% in Q1 2026, and 41.87% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 44.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.22% |
| Mar 31, 2026 | 44.97% |
| Dec 31, 2025 | 41.87% |
| Sep 30, 2025 | 46.69% |
| Jun 30, 2025 | 44.47% |
| Mar 31, 2025 | 40.37% |
| Dec 31, 2024 | 38.58% |
| Sep 30, 2024 | 45.44% |
| Jun 30, 2024 | 50.42% |
| Mar 31, 2024 | 49.39% |
| Dec 31, 2023 | 40.16% |
| Sep 30, 2023 | 43.61% |
| Jun 30, 2023 | 46.00% |
| Mar 31, 2023 | 42.85% |
| Dec 31, 2022 | 28.58% |
| Sep 30, 2022 | 38.10% |
| Jun 30, 2022 | 36.65% |
| Mar 31, 2022 | 30.88% |
| Dec 31, 2021 | 29.91% |
| Sep 30, 2021 | 43.21% |